Global Oral Anti-Diabetic Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oral Anti-Diabetic Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Oral Anti-Diabetic Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Oral Anti-Diabetic Drug by Country/Region, 2017, 2022 & 2028

2.2 Oral Anti-Diabetic Drug Segment by Type

2.2.1 Glimepiride

2.2.2 Gliclazide

2.2.3 Glyburide

2.2.4 Others

2.3 Oral Anti-Diabetic Drug Sales by Type

2.3.1 Global Oral Anti-Diabetic Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Oral Anti-Diabetic Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Oral Anti-Diabetic Drug Sale Price by Type (2017-2022)

2.4 Oral Anti-Diabetic Drug Segment by Application

2.4.1 Hospital

2.4.2 Research Institual

2.5 Oral Anti-Diabetic Drug Sales by Application

2.5.1 Global Oral Anti-Diabetic Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Oral Anti-Diabetic Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Oral Anti-Diabetic Drug Sale Price by Application (2017-2022)

3 Global Oral Anti-Diabetic Drug by Company

3.1 Global Oral Anti-Diabetic Drug Breakdown Data by Company

3.1.1 Global Oral Anti-Diabetic Drug Annual Sales by Company (2020-2022)

3.1.2 Global Oral Anti-Diabetic Drug Sales Market Share by Company (2020-2022)

3.2 Global Oral Anti-Diabetic Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Oral Anti-Diabetic Drug Revenue by Company (2020-2022)

3.2.2 Global Oral Anti-Diabetic Drug Revenue Market Share by Company (2020-2022)

3.3 Global Oral Anti-Diabetic Drug Sale Price by Company

3.4 Key Manufacturers Oral Anti-Diabetic Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Oral Anti-Diabetic Drug Product Location Distribution

3.4.2 Players Oral Anti-Diabetic Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oral Anti-Diabetic Drug by Geographic Region

4.1 World Historic Oral Anti-Diabetic Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Oral Anti-Diabetic Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Oral Anti-Diabetic Drug Annual Revenue by Geographic Region

4.2 World Historic Oral Anti-Diabetic Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Oral Anti-Diabetic Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Oral Anti-Diabetic Drug Annual Revenue by Country/Region

4.3 Americas Oral Anti-Diabetic Drug Sales Growth

4.4 APAC Oral Anti-Diabetic Drug Sales Growth

4.5 Europe Oral Anti-Diabetic Drug Sales Growth

4.6 Middle East & Africa Oral Anti-Diabetic Drug Sales Growth

5 Americas

5.1 Americas Oral Anti-Diabetic Drug Sales by Country

5.1.1 Americas Oral Anti-Diabetic Drug Sales by Country (2017-2022)

5.1.2 Americas Oral Anti-Diabetic Drug Revenue by Country (2017-2022)

5.2 Americas Oral Anti-Diabetic Drug Sales by Type

5.3 Americas Oral Anti-Diabetic Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oral Anti-Diabetic Drug Sales by Region

6.1.1 APAC Oral Anti-Diabetic Drug Sales by Region (2017-2022)

6.1.2 APAC Oral Anti-Diabetic Drug Revenue by Region (2017-2022)

6.2 APAC Oral Anti-Diabetic Drug Sales by Type

6.3 APAC Oral Anti-Diabetic Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Oral Anti-Diabetic Drug by Country

7.1.1 Europe Oral Anti-Diabetic Drug Sales by Country (2017-2022)

7.1.2 Europe Oral Anti-Diabetic Drug Revenue by Country (2017-2022)

7.2 Europe Oral Anti-Diabetic Drug Sales by Type

7.3 Europe Oral Anti-Diabetic Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oral Anti-Diabetic Drug by Country

8.1.1 Middle East & Africa Oral Anti-Diabetic Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Oral Anti-Diabetic Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Oral Anti-Diabetic Drug Sales by Type

8.3 Middle East & Africa Oral Anti-Diabetic Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Oral Anti-Diabetic Drug

10.3 Manufacturing Process Analysis of Oral Anti-Diabetic Drug

10.4 Industry Chain Structure of Oral Anti-Diabetic Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Oral Anti-Diabetic Drug Distributors

11.3 Oral Anti-Diabetic Drug Customer

12 World Forecast Review for Oral Anti-Diabetic Drug by Geographic Region

12.1 Global Oral Anti-Diabetic Drug Market Size Forecast by Region

12.1.1 Global Oral Anti-Diabetic Drug Forecast by Region (2023-2028)

12.1.2 Global Oral Anti-Diabetic Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Oral Anti-Diabetic Drug Forecast by Type

12.7 Global Oral Anti-Diabetic Drug Forecast by Application

13 Key Players Analysis

13.1 Takeda

13.1.1 Takeda Company Information

13.1.2 Takeda Oral Anti-Diabetic Drug Product Offered

13.1.3 Takeda Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Takeda Main Business Overview

13.1.5 Takeda Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Oral Anti-Diabetic Drug Product Offered

13.2.3 Pfizer Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Eli Lilly

13.3.1 Eli Lilly Company Information

13.3.2 Eli Lilly Oral Anti-Diabetic Drug Product Offered

13.3.3 Eli Lilly Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Eli Lilly Main Business Overview

13.3.5 Eli Lilly Latest Developments

13.4 Janssen Pharmaceuticals

13.4.1 Janssen Pharmaceuticals Company Information

13.4.2 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Offered

13.4.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Janssen Pharmaceuticals Main Business Overview

13.4.5 Janssen Pharmaceuticals Latest Developments

13.5 Astellas

13.5.1 Astellas Company Information

13.5.2 Astellas Oral Anti-Diabetic Drug Product Offered

13.5.3 Astellas Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Astellas Main Business Overview

13.5.5 Astellas Latest Developments

13.6 Boehringer Ingelheim

13.6.1 Boehringer Ingelheim Company Information

13.6.2 Boehringer Ingelheim Oral Anti-Diabetic Drug Product Offered

13.6.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Boehringer Ingelheim Main Business Overview

13.6.5 Boehringer Ingelheim Latest Developments

13.7 Merck And Co.

13.7.1 Merck And Co. Company Information

13.7.2 Merck And Co. Oral Anti-Diabetic Drug Product Offered

13.7.3 Merck And Co. Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck And Co. Main Business Overview

13.7.5 Merck And Co. Latest Developments

13.8 AstraZeneca

13.8.1 AstraZeneca Company Information

13.8.2 AstraZeneca Oral Anti-Diabetic Drug Product Offered

13.8.3 AstraZeneca Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 AstraZeneca Main Business Overview

13.8.5 AstraZeneca Latest Developments

13.9 Bristol Myers Squibb

13.9.1 Bristol Myers Squibb Company Information

13.9.2 Bristol Myers Squibb Oral Anti-Diabetic Drug Product Offered

13.9.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bristol Myers Squibb Main Business Overview

13.9.5 Bristol Myers Squibb Latest Developments

13.10 Novartis

13.10.1 Novartis Company Information

13.10.2 Novartis Oral Anti-Diabetic Drug Product Offered

13.10.3 Novartis Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis Main Business Overview

13.10.5 Novartis Latest Developments

13.11 Sanofi

13.11.1 Sanofi Company Information

13.11.2 Sanofi Oral Anti-Diabetic Drug Product Offered

13.11.3 Sanofi Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Sanofi Main Business Overview

13.11.5 Sanofi Latest Developments

13.12 Abbott

13.12.1 Abbott Company Information

13.12.2 Abbott Oral Anti-Diabetic Drug Product Offered

13.12.3 Abbott Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Abbott Main Business Overview

13.12.5 Abbott Latest Developments

13.13 Biocon

13.13.1 Biocon Company Information

13.13.2 Biocon Oral Anti-Diabetic Drug Product Offered

13.13.3 Biocon Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Biocon Main Business Overview

13.13.5 Biocon Latest Developments

14 Research Findings and Conclusion

Table 1. Oral Anti-Diabetic Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Oral Anti-Diabetic Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Glimepiride

Table 4. Major Players of Gliclazide

Table 5. Major Players of Glyburide

Table 6. Major Players of Others

Table 7. Global Oral Anti-Diabetic Drug Sales by Type (2017-2022) & (K Tons)

Table 8. Global Oral Anti-Diabetic Drug Sales Market Share by Type (2017-2022)

Table 9. Global Oral Anti-Diabetic Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Oral Anti-Diabetic Drug Sale Price by Type (2017-2022) & (USD/Ton)

Table 12. Global Oral Anti-Diabetic Drug Sales by Application (2017-2022) & (K Tons)

Table 13. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2017-2022)

Table 14. Global Oral Anti-Diabetic Drug Revenue by Application (2017-2022)

Table 15. Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Oral Anti-Diabetic Drug Sale Price by Application (2017-2022) & (USD/Ton)

Table 17. Global Oral Anti-Diabetic Drug Sales by Company (2020-2022) & (K Tons)

Table 18. Global Oral Anti-Diabetic Drug Sales Market Share by Company (2020-2022)

Table 19. Global Oral Anti-Diabetic Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Oral Anti-Diabetic Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Oral Anti-Diabetic Drug Sale Price by Company (2020-2022) & (USD/Ton)

Table 22. Key Manufacturers Oral Anti-Diabetic Drug Producing Area Distribution and Sales Area

Table 23. Players Oral Anti-Diabetic Drug Products Offered

Table 24. Oral Anti-Diabetic Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Oral Anti-Diabetic Drug Sales by Geographic Region (2017-2022) & (K Tons)

Table 28. Global Oral Anti-Diabetic Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Oral Anti-Diabetic Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Oral Anti-Diabetic Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Oral Anti-Diabetic Drug Sales by Country/Region (2017-2022) & (K Tons)

Table 32. Global Oral Anti-Diabetic Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Oral Anti-Diabetic Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Oral Anti-Diabetic Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Oral Anti-Diabetic Drug Sales by Country (2017-2022) & (K Tons)

Table 36. Americas Oral Anti-Diabetic Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Oral Anti-Diabetic Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Oral Anti-Diabetic Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Oral Anti-Diabetic Drug Sales by Type (2017-2022) & (K Tons)

Table 40. Americas Oral Anti-Diabetic Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Oral Anti-Diabetic Drug Sales by Application (2017-2022) & (K Tons)

Table 42. Americas Oral Anti-Diabetic Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Oral Anti-Diabetic Drug Sales by Region (2017-2022) & (K Tons)

Table 44. APAC Oral Anti-Diabetic Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Oral Anti-Diabetic Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Oral Anti-Diabetic Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Oral Anti-Diabetic Drug Sales by Type (2017-2022) & (K Tons)

Table 48. APAC Oral Anti-Diabetic Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Oral Anti-Diabetic Drug Sales by Application (2017-2022) & (K Tons)

Table 50. APAC Oral Anti-Diabetic Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Oral Anti-Diabetic Drug Sales by Country (2017-2022) & (K Tons)

Table 52. Europe Oral Anti-Diabetic Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Oral Anti-Diabetic Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Oral Anti-Diabetic Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Oral Anti-Diabetic Drug Sales by Type (2017-2022) & (K Tons)

Table 56. Europe Oral Anti-Diabetic Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Oral Anti-Diabetic Drug Sales by Application (2017-2022) & (K Tons)

Table 58. Europe Oral Anti-Diabetic Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Oral Anti-Diabetic Drug Sales by Country (2017-2022) & (K Tons)

Table 60. Middle East & Africa Oral Anti-Diabetic Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Oral Anti-Diabetic Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Oral Anti-Diabetic Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Oral Anti-Diabetic Drug Sales by Type (2017-2022) & (K Tons)

Table 64. Middle East & Africa Oral Anti-Diabetic Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Oral Anti-Diabetic Drug Sales by Application (2017-2022) & (K Tons)

Table 66. Middle East & Africa Oral Anti-Diabetic Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Oral Anti-Diabetic Drug

Table 68. Key Market Challenges & Risks of Oral Anti-Diabetic Drug

Table 69. Key Industry Trends of Oral Anti-Diabetic Drug

Table 70. Oral Anti-Diabetic Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Oral Anti-Diabetic Drug Distributors List

Table 73. Oral Anti-Diabetic Drug Customer List

Table 74. Global Oral Anti-Diabetic Drug Sales Forecast by Region (2023-2028) & (K Tons)

Table 75. Global Oral Anti-Diabetic Drug Sales Market Forecast by Region

Table 76. Global Oral Anti-Diabetic Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Oral Anti-Diabetic Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Oral Anti-Diabetic Drug Sales Forecast by Country (2023-2028) & (K Tons)

Table 79. Americas Oral Anti-Diabetic Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Oral Anti-Diabetic Drug Sales Forecast by Region (2023-2028) & (K Tons)

Table 81. APAC Oral Anti-Diabetic Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Oral Anti-Diabetic Drug Sales Forecast by Country (2023-2028) & (K Tons)

Table 83. Europe Oral Anti-Diabetic Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Oral Anti-Diabetic Drug Sales Forecast by Country (2023-2028) & (K Tons)

Table 85. Middle East & Africa Oral Anti-Diabetic Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Oral Anti-Diabetic Drug Sales Forecast by Type (2023-2028) & (K Tons)

Table 87. Global Oral Anti-Diabetic Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Oral Anti-Diabetic Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Oral Anti-Diabetic Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Oral Anti-Diabetic Drug Sales Forecast by Application (2023-2028) & (K Tons)

Table 91. Global Oral Anti-Diabetic Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Oral Anti-Diabetic Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Oral Anti-Diabetic Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. Takeda Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Takeda Oral Anti-Diabetic Drug Product Offered

Table 96. Takeda Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 97. Takeda Main Business

Table 98. Takeda Latest Developments

Table 99. Pfizer Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Pfizer Oral Anti-Diabetic Drug Product Offered

Table 101. Pfizer Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 102. Pfizer Main Business

Table 103. Pfizer Latest Developments

Table 104. Eli Lilly Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Eli Lilly Oral Anti-Diabetic Drug Product Offered

Table 106. Eli Lilly Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 107. Eli Lilly Main Business

Table 108. Eli Lilly Latest Developments

Table 109. Janssen Pharmaceuticals Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Offered

Table 111. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 112. Janssen Pharmaceuticals Main Business

Table 113. Janssen Pharmaceuticals Latest Developments

Table 114. Astellas Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. Astellas Oral Anti-Diabetic Drug Product Offered

Table 116. Astellas Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 117. Astellas Main Business

Table 118. Astellas Latest Developments

Table 119. Boehringer Ingelheim Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Boehringer Ingelheim Oral Anti-Diabetic Drug Product Offered

Table 121. Boehringer Ingelheim Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 122. Boehringer Ingelheim Main Business

Table 123. Boehringer Ingelheim Latest Developments

Table 124. Merck And Co. Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Merck And Co. Oral Anti-Diabetic Drug Product Offered

Table 126. Merck And Co. Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 127. Merck And Co. Main Business

Table 128. Merck And Co. Latest Developments

Table 129. AstraZeneca Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. AstraZeneca Oral Anti-Diabetic Drug Product Offered

Table 131. AstraZeneca Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 132. AstraZeneca Main Business

Table 133. AstraZeneca Latest Developments

Table 134. Bristol Myers Squibb Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. Bristol Myers Squibb Oral Anti-Diabetic Drug Product Offered

Table 136. Bristol Myers Squibb Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 137. Bristol Myers Squibb Main Business

Table 138. Bristol Myers Squibb Latest Developments

Table 139. Novartis Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. Novartis Oral Anti-Diabetic Drug Product Offered

Table 141. Novartis Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 142. Novartis Main Business

Table 143. Novartis Latest Developments

Table 144. Sanofi Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 145. Sanofi Oral Anti-Diabetic Drug Product Offered

Table 146. Sanofi Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 147. Sanofi Main Business

Table 148. Sanofi Latest Developments

Table 149. Abbott Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 150. Abbott Oral Anti-Diabetic Drug Product Offered

Table 151. Abbott Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 152. Abbott Main Business

Table 153. Abbott Latest Developments

Table 154. Biocon Basic Information, Oral Anti-Diabetic Drug Manufacturing Base, Sales Area and Its Competitors

Table 155. Biocon Oral Anti-Diabetic Drug Product Offered

Table 156. Biocon Oral Anti-Diabetic Drug Sales (K Tons), Revenue ($ Million), Price (USD/Ton) and Gross Margin (2020-2022)

Table 157. Biocon Main Business

Table 158. Biocon Latest Developments

List of Figures

Figure 1. Picture of Oral Anti-Diabetic Drug

Figure 2. Oral Anti-Diabetic Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Oral Anti-Diabetic Drug Sales Growth Rate 2017-2028 (K Tons)

Figure 7. Global Oral Anti-Diabetic Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Oral Anti-Diabetic Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Glimepiride

Figure 10. Product Picture of Gliclazide

Figure 11. Product Picture of Glyburide

Figure 12. Product Picture of Others

Figure 13. Global Oral Anti-Diabetic Drug Sales Market Share by Type in 2021

Figure 14. Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2017-2022)

Figure 15. Oral Anti-Diabetic Drug Consumed in Hospital

Figure 16. Global Oral Anti-Diabetic Drug Market: Hospital (2017-2022) & (K Tons)

Figure 17. Oral Anti-Diabetic Drug Consumed in Research Institual

Figure 18. Global Oral Anti-Diabetic Drug Market: Research Institual (2017-2022) & (K Tons)

Figure 19. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2017-2022)

Figure 20. Global Oral Anti-Diabetic Drug Revenue Market Share by Application in 2021

Figure 21. Oral Anti-Diabetic Drug Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Oral Anti-Diabetic Drug Revenue Market Share by Company in 2021

Figure 23. Global Oral Anti-Diabetic Drug Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Oral Anti-Diabetic Drug Revenue Market Share by Geographic Region in 2021

Figure 25. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2017-2022)

Figure 26. Global Oral Anti-Diabetic Drug Revenue Market Share by Country/Region in 2021

Figure 27. Americas Oral Anti-Diabetic Drug Sales 2017-2022 (K Tons)

Figure 28. Americas Oral Anti-Diabetic Drug Revenue 2017-2022 ($ Millions)

Figure 29. APAC Oral Anti-Diabetic Drug Sales 2017-2022 (K Tons)

Figure 30. APAC Oral Anti-Diabetic Drug Revenue 2017-2022 ($ Millions)

Figure 31. Europe Oral Anti-Diabetic Drug Sales 2017-2022 (K Tons)

Figure 32. Europe Oral Anti-Diabetic Drug Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Oral Anti-Diabetic Drug Sales 2017-2022 (K Tons)

Figure 34. Middle East & Africa Oral Anti-Diabetic Drug Revenue 2017-2022 ($ Millions)

Figure 35. Americas Oral Anti-Diabetic Drug Sales Market Share by Country in 2021

Figure 36. Americas Oral Anti-Diabetic Drug Revenue Market Share by Country in 2021

Figure 37. United States Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Oral Anti-Diabetic Drug Sales Market Share by Region in 2021

Figure 42. APAC Oral Anti-Diabetic Drug Revenue Market Share by Regions in 2021

Figure 43. China Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Oral Anti-Diabetic Drug Sales Market Share by Country in 2021

Figure 50. Europe Oral Anti-Diabetic Drug Revenue Market Share by Country in 2021

Figure 51. Germany Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Oral Anti-Diabetic Drug Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Oral Anti-Diabetic Drug Revenue Market Share by Country in 2021

Figure 58. Egypt Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Oral Anti-Diabetic Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Oral Anti-Diabetic Drug in 2021

Figure 64. Manufacturing Process Analysis of Oral Anti-Diabetic Drug

Figure 65. Industry Chain Structure of Oral Anti-Diabetic Drug

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles